First-in-Human Study of ADCE-D01 in Soft Tissue Sarcoma | MicrobiomeTrials← Back to trialsNCT06797999
First-in-Human Study of ADCE-D01 in Soft Tissue Sarcoma
RecruitingPHASE1, PHASE2INTERVENTIONAL
Trial Details
Start: 2025-06-05Est. Completion: 2029-02-27
Enrollment target: 270 participants Locations- University of Colorado Denver, Aurora, Colorado, United States
- University of Miami - Sylvester Comprehensive Cancer Center, Miami, Florida, United States
- Memorial Sloan Kettering Cancer Center, New York, New York, United States
- University Of Texas MD Anderson Cancer Center, Houston, Texas, United States
- Universitair Ziekenhuis Leuven (UZ Leuven) - Campus Gasthuisberg, Leuven, Belgium
- Institut Gustave Roussy, Paris, Ville Juif Cedex, France
- Centre Léon Bérard, Lyon, France
- Universitätsklinikum Essen West German Tumor Center, Essen, Germany
- Royal Marsden, London, United Kingdom
Other microbiome trials you might be interested in
Colorectal Neoplasms
The main purpose of this study is to evaluate how well olomorasib is tolerated and what side effects may occur when comb…
Multiple LocationsEst. completion Nov 2028
Metastatic Malignant Skin NeoplasmMetastatic Malignant Soft Tissue NeoplasmRecurrent Malignant Skin NeoplasmRecurrent Malignant Soft Tissue NeoplasmSkin NeoplasmSoft Tissue Neoplasm
This clinical trial tests the safety and best dose of minibeam radiation therapy (MBRT) with a tungsten slit collimator …
Rochester, United States
Est. completion Aug 1, 2028